Areteia Therapeutics Funding & Investors
Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eosinophilic asthma.
areteiatx.comTotal Amount Raised: $425,000,000
Areteia Therapeutics Funding Rounds
Series A
$75,000,000
Series A Investors
Bain Capital Life SciencesSaturn PartnersPopulation Health PartnersSanofiAccess BiotechnologyViking Global InvestorsGVMaverick CapitalArch Venture PartnersMarshall WaceSeries A
$350,000,000
Series A Investors
Bain Capital Life SciencesArch Venture PartnersMaverick CapitalGVPopulation Health PartnersAccess BiotechnologySanofiSaturn Partners
Funding info provided by Diffbot.